Literature DB >> 17189820

Labetalol causing intraoperative floppy-iris syndrome.

Fadi Calotti, Daniel Steen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17189820     DOI: 10.1016/j.jcrs.2006.07.048

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


× No keyword cloud information.
  7 in total

1.  Correlation between urological alpha1-AR antagonist medication and changed intraoperative iris behavior.

Authors:  Karin Horvath; Florina Vultur
Journal:  Int Ophthalmol       Date:  2011-01-29       Impact factor: 2.031

2.  Risk factors for intraoperative floppy iris syndrome: a prospective study.

Authors:  I P Chatziralli; V Peponis; E Parikakis; A Maniatea; E Patsea; P Mitropoulos
Journal:  Eye (Lond)       Date:  2016-07-01       Impact factor: 3.775

3.  Urologic medications and ophthalmologic side effects: a review.

Authors:  Johan Gani; Nathan Perlis; Sidney B Radomski
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

4.  Alpha-blockers and intraoperative floppy iris syndrome: ophthalmic adverse events following cataract surgery.

Authors:  Zuhair K Al-Hussaini; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 5.  The floppy iris syndrome - what urologists and ophthalmologists need to know.

Authors:  Faruquz Zaman; Christian Bach; Islam Junaid; Athanasios G Papatsoris; Jhumur Pati; Junaid Masood; Noor Buchholz
Journal:  Curr Urol       Date:  2012-04-30

Review 6.  Complications of cataract surgery in patients with BPH treated with alpha 1A-blockers.

Authors:  Slawomir Jan Teper; Dariusz Dobrowolski; Edward Wylegala
Journal:  Cent European J Urol       Date:  2011-06-02

7.  Intraoperative floppy iris syndrome in Indian population: a prospective study on incidence, risk factors, and impact on operative performance.

Authors:  Shilpa Goyal; Deepansh Dalela; Neeraj Kumar Goyal; Shobhit Chawla; Rajat Dhesi; Bela Kamboj; Abha Dalela
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.